Results 181 to 190 of about 65,232 (224)

Comparative phylogenetic analysis of breast cancer susceptibility genes reveals evolutionary conservation supporting diagnostic barcode design. [PDF]

Ann Med Surg (Lond)
Rehman SU.
europepmc   +1 more source

From Diagnosis to Disclosure: Navigating Genetic Counseling Dilemmas in <i>BRCA2</i>-Associated Prostate Cancer in the Middle East. [PDF]

Case Rep Genet
van Wyk C, Abdulrahim R, Crous I, Al Saegh A, Al Balushi A, Al Muhairi B, Al Kiyumi S, Al Malki S, Al Harthy M.   +8 more
europepmc   +1 more source

Differential roles of BRCA1 and BRCA2 in the DNA damage response revealed by isogenic V79 mutant cell lines. [PDF]

Mutagenesis
Chailapakul P, Maeda J, Miura T, Kato TA.   +3 more
europepmc   +1 more source

G-quadruplex homeostasis is a determinant of PARP inhibitor toxicity in BRCA2-deficient cells. [PDF]

Nat Commun
Sharma AB, Krwawicz J, Tappenden L, Ramlee MK, Abugable AA, Zhen X, Khurana S, Stracker TH, Lakin ND.   +8 more
europepmc   +1 more source

Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer. [PDF]

J Cancer Res Clin Oncol
Doraczynska-Kowalik A, Matkowski R, Michalowska D, Chrusciel A, Semeniuk M, Blomka D, Lawicka P, Czykalko E, Abrahamowska M, Pietron A, Janus-Szymanska G, Pawlak I, Maciejczyk A, Szelachowska J, Laczmanska I.   +14 more
europepmc   +1 more source

BCLX_L blockade rewires cell fate to overcome PARP inhibitor resistance in ovarian cancer. [PDF]

Signal Transduct Target Ther
Venkatachalam A, Strathman AR, Hou X, Correia C, Meng XW, McGehee CD, Balczewski EA, Duffield LN, Rossman OK, Wong C, Dai H, Hurley RM, Wagner JM, Singh S, Flatten KS, Peterson KL, Schneider PA, De Lorenzo SB, Larson MC, Oberg AL, Wahner Hendrickson AE, Wu X, Pandey A, Li H, Weroha SJ, Kaufmann SH.   +25 more
europepmc   +1 more source

Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India. [PDF]

Cancer Med
Sherigar P, Kedlaya Herga S, Pai A, Mailankody S, Udupa KS.   +4 more
europepmc   +1 more source

Correction to: Reclassification of a BRCA2 variant, c.8487G > A (p.Gln2829Gln) located at 3' end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case report. [PDF]

Jpn J Clin Oncol
europepmc   +1 more source

Examining the connection between BRCA1/2 mutations and uterine cancer: a comprehensive review. [PDF]

Ann Med Surg (Lond)
Saleem SM, Nasir SAS, Nida F, Khalid M, Gandhi H, Javaid MH, Roy A.   +6 more
europepmc   +1 more source

BRCA Testing in Prostate Cancer: A Histopathologist's Perspective. [PDF]

Diagnostics (Basel)
Sanguedolce F, Mazzucchelli R, Conteduca V, Maiorano BA.   +3 more
europepmc   +1 more source